LAG3 and Patent ductus arteriosus: Therefore, even though there was an increase in TIM-3 and LAG-3 on CAR T cells after their engagement with PDA cells, we preferred to manipulate the ICs from the PDA tumor side, in another word, on PD-L1 molecule.